随着 DeSci 势头的增强，SUI DeSci Agent 宣布项目启动

SUI DeSci Agent 是一个旨在帮助零售受众注入长寿研究突破的平台，该平台已宣布启动其项目

Retail audiences can now enjoy direct access to longevity research breakthroughs with the launch of SUI DeSci Agents, a platform that is set to revolutionize the DeSci landscape.

随着 SUI DeSci Agents 的推出，零售受众现在可以直接获得长寿研究突破，该平台将彻底改变 DeSci 格局。

According to an official announcement on Friday, the platform’s launch comes as part of a broader effort to provide retail users with exclusive and democratized access to longevity research. This development positions SUI DeSci Agents as a leading project within the rapidly evolving DeSci space.

根据周五的一份官方公告，该平台的推出是为零售用户提供独家和民主化的长寿研究机会的更广泛努力的一部分。这一开发使 SUI DeSci Agents 成为快速发展的 DeSci 领域的领先项目。

As part of its design, SUI DeSci Agents is dedicated to launching DeSci assets, expanding their audience through AI agents, and generating liquidity through advanced mechanics inspired by pump.fun.

作为其设计的一部分，SUI DeSci Agents 致力于推出 DeSci 资产，通过人工智能代理扩大受众，并通过受 Pump.fun 启发的先进机制产生流动性。

Coinciding with its entry into the DeSci ecosystem, the launch also introduces the platform's native token, $DESCI. This token will grant users access to a range of unique features, including tokenized compounds, pluggable AI agents, layer-2 liquidity mechanics, and AI-powered B2C products.

在进入 DeSci 生态系统的同时，此次发布还推出了该平台的原生代币 $DESCI。该代币将允许用户访问一系列独特的功能，包括代币化化合物、可插入的人工智能代理、第 2 层流动性机制和人工智能驱动的 B2C 产品。

With these features, users can wager on the potential of longevity compounds, such as Epitalon and Rapamycin (the first compounds to be launched), by analyzing their scientific data and statistics. The project also pairs LLM-trained AI agents with longevity compounds, engaging them in 24/7 promotion across social platforms to ensure optimal outreach.

借助这些功能，用户可以通过分析科学数据和统计数据来押注长寿化合物的潜力，例如 Epitalon 和雷帕霉素（第一个推出的化合物）。该项目还将受过法学硕士培训的人工智能代理与长寿化合物配对，让他们在社交平台上进行 24/7 的推广，以确保最佳的推广。

Significantly, the platform aims to establish a robust liquidity ecosystem tailored for DeSci, fostering organic growth and supporting the broader ecosystem.

值得注意的是，该平台旨在建立一个专为 DeSci 定制的强大的流动性生态系统，促进有机增长并支持更广泛的生态系统。

DeSci's Potential as the Next Major Trend For 2025

DeSci 有望成为 2025 年下一个主要趋势

Emerging rapidly to address systemic inefficiencies in traditional scientific research, such as bureaucratic funding processes, underfunded breakthrough opportunities, and limited retail access to longevity investments, DeSci has garnered increasing attention.

DeSci 迅速崛起，旨在解决传统科学研究中的系统性低效率问题，例如官僚融资流程、资金不足的突破机会以及零售长寿投资的渠道有限，它引起了越来越多的关注。

This momentum was further propelled by key leaders, including Vitalik Buterin, who highlighted the transformative potential of DeSci projects at the recent Devcon event.

这一势头得到了关键领导人的进一步推动，其中包括 Vitalik Buterin，他在最近的 Devcon 活动中强调了 DeSci 项目的变革潜力。

In other developments, Coinbase founder Brian Armstrong expressed support for ResearchHub to foster open scientific collaboration. A16Z also led a $5M funding round for AminoChain, a decentralized biosample marketplace.

在其他进展中，Coinbase 创始人布莱恩·阿姆斯特朗 (Brian Armstrong) 表示支持 ResearchHub 促进开放的科学合作。 A16Z 还领投了去中心化生物样本市场 AminoChain 的 500 万美元融资。

Moreover, Pfizer Ventures participated in a $4.1M funding round of VitaDAO, a project focused on raising funds for research that expands human lifespan.

此外，辉瑞风险投资公司还参与了 VitaDAO 的 410 万美元融资，该项目专注于为延长人类寿命的研究筹集资金。

As DeSci continues to gain steam, SUI DeSci Agents is aiming to create a platform where retail audiences can invest in tokenized longevity compounds. The project will also introduce AI-powered B2C wellness tools to assist SUI Desci Agents in onboarding more users into the ecosystem.

随着 DeSci 的不断发展，SUI DeSci Agents 的目标是创建一个平台，让零售受众可以投资代币化的长寿化合物。该项目还将引入人工智能驱动的 B2C 健康工具，以协助 SUI Desci Agents 吸引更多用户进入生态系统。